Skip to main content
. Author manuscript; available in PMC: 2015 Apr 11.
Published in final edited form as: Vaccine. 2014 Feb 18;32(18):2109–2116. doi: 10.1016/j.vaccine.2014.02.001

Figure 5. Comparison of clade C gp140 binding antibody responses in non-human primates in select adjuvants.

Figure 5

Serum samples obtained 4-weeks after clade C gp140 immunizations in either Matrix M, GLA-Aqueous or virosome adjuvants were analyzed in endpoint ELISAs for binding antibody responses against clade C gp140. Horizontal broken line represents assay background threshold. Pre = pre-vaccination (*P<0.05; unpaired t-test)